2. Signaling Pathways
  3. Immunology/Inflammation
  4. CD28
  5. CD28 Agonist

CD28 Agonist

CD28 Agonist (1):

Cat. No. Product Name Effect Purity
  • HY-P9975
    Theralizumab
    		Agonist 99.46%
    Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.